Matthew J. Giacalone, Ph.D.
Affiliations: | 2006 | University of California, San Diego and San Diego State University |
Area:
Microbiology Biology, Cell Biology, Virology BiologyGoogle:
"Matthew Giacalone"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Kathleen L. McGuire | grad student | 2006 | University of California, San Diego and San Diego State University | |
| (The use of bacterial minicells as a broad spectrum vaccine delivery vehicle.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Grenier SF, Khan MW, Reil KA, et al. (2023) VAX014, an Oncolytic Therapy, Reduces Adenomas and Modifies Colon Microenvironment in Mouse Model of CRC. International Journal of Molecular Sciences. 24 |
| Reil KA, Tsuji S, Molina E, et al. (2023) Intralesional administration of VAX014 facilitates in situ immunization and potentiates immune checkpoint blockade in immunologically cold tumors. Journal For Immunotherapy of Cancer. 11 |
| Tsuji S, Reil K, Nelson K, et al. (2022) Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer. Cancer Immunology Research |
| Hancock BM, McGuire KL, Tsuji S, et al. (2016) A Single Intravesical Instillation of VAX014 Inhibits Orthotopic Superficial Bladder Tumor Implantation to Increase Survival. Anticancer Research. 36: 6243-6248 |
| Tsuji S, Chen X, Hancock B, et al. (2016) Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer. Molecular Therapy Oncolytics. 3: 16004 |
| Khan MW, Tsuji S, Tian M, et al. (2016) Abstract A05: Immunity, the colonic environment, and colon cancer Cancer Research. 76 |
| Newman MJ, Benbatoul K, Hancock B, et al. (2012) Abstract 5703: Efficient targeted delivery of protein toxins using self-manufacturing nanoparticles (minicells) derived from bacteria Cancer Research. 72: 5703-5703 |
| Giacalone MJ, Zapata JC, Berkley NL, et al. (2007) Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus. Vaccine. 25: 2279-87 |
| Giacalone MJ, Sabbadini RA, Chambers AL, et al. (2007) Corrigendum to "Immune responses elicited by bacterial minicells capable of simultaneous DNA and protein antigen delivery" [Vaccine 2006;24(33-34):6009-6017] (DOI:10.1016/j.vaccine.2006.04.063) Vaccine. 25: 3515 |
| Giacalone MJ, Gentile AM, Lovitt BT, et al. (2006) The use of bacterial minicells to transfer plasmid DNA to eukaryotic cells. Cellular Microbiology. 8: 1624-33 |